for more information about stanelco click on the links.

driver's research page link
http://www.moneyam.com/InvestorsRoom/posts.php?tid=7681#lastread
website link
http://www.stanelco.co.uk/index.htm

Ahhh, just the way us mushrooms like it!

garyble, i thought maybe the electrickery had been switched off, non payment of bills etc

Catweasel fan???

loved it

showing your age.
only being 27, I have seen it on UKTV Gold ;-)

my mum told me all about it??

na twas good that one, don't make em like that anymore, how long before someone posts(thank *&%$# for that

For the whippersnappers out there;

alan, i will have to show my neighbour these phots, i reckon he's Catweasels brother, frightning i didn't realise how ugly he was

Starpol and WRAP down under ?

TopAnalyst -
If you follow the link it leads you to blueboomerang.com an online business directory SEO is the forth one down so it looks like an addvert to me.

Stanelco PLC
29 May 2007

29th May 2007



Stanelco plc('Stanelco' or 'the Company')

Trading Statement

Following the appointment of Paul Mines as Chief Executive Officer of the
Company on 16 April 2007, a preliminary review of the business operations of the
Company has been conducted. The results of that review were presented to the
Board on 25 May 2007.

The principal conclusions from the review are as follows:

1. Biotec

Biotec, which is owned 50 per cent. by Stanelco and 50 per cent. by SPhere S.A.,
sells virtually all of its biopolymer output to its shareholders. In the current
financial year to 31 December 2007, it was envisaged that each shareholder would
take approximately half of the production capacity of biopolymer and Biotec has
prepared itself for that eventuality. However, the Stanelco sales and product
pipeline is currently nascent and is expected to be developed over the course of
the next 18 months or so.

Given this, and other strategic constraints, the plans to manufacture Biotec
materials in the USA have been placed on hold.

In addition, the Board has become aware of certain patent challenges lodged
against some of Biotec's products and is currently evaluating the significance
of these challenges.

2. Radio Frequency (RF) Applications

The Greenseal trials have now been concluded. Unfortunately, the Board's
assessment of the result of these trials is that they are unlikely to lead to
any commercial sales for this particular application. Underlying trading at the
RF division remains steady.

3. Aquasol

An agreement has been reached to sell certain assets of Adept to MonoSol AF
Limited for approximately 494,000 and this may lead to the possible future
licensing of Aquasol's FrogMat intellectual property. Shareholders will be kept
fully informed of further developments in this regard.

Development continues to commercialise other Aquasol intellectual property.

4. Cash flow

Our cash balance at 30 April 2007 was approximately 11 million. We are
committed to ensure that these funds are deployed successfully towards a cash
positive trading position. Accordingly, the cost base of the business is being
kept under review and further cost reductions are envisaged.

Trading expectations for this financial year will be adversely affected by the
above.

The Board remains encouraged by market trends and customer interest in the
Company's portfolio of products and intellectual property and is developing its
plans in the short term to deliver shareholder value from these assets over the
medium term.

A full trading update will be provided with the half year results.


For further information please contact:

Financial Dynamics
Jonathon Brill/Caroline Stewart
Tel: +44 (0) 20 7831 3113




This information is provided by RNS
The company news service from the London Stock Exchange

Looks bloody awful to me.

This is bloody awful!The two products that were going to be the good news for this Company are now being shelved -1. no biopolymer output in the states.2.Greenseal which should have changed the packaging industry has no commercial sales.

This will take a lot to recover from in the short term and also Biotec products in dispute so that could drag on for ages

pt.not so positive today well here anyway.

last one out turn the lights off , please.

So promises, promises have come to nothing....BUT....... "The Board remains encouraged by market trends and customer interest in the company's portfolio of products and intellectual property and is developing its plans in the short term to deliver shareholder value from these assets over the medium term".........

So thats alright then.

I wonder if the mentioned patent challenges go ahead, if Stanleco have the will (or the cash) to fight them.

This RNS release is to me the catalyst of proof how pathetic the management of this company has been over the last 3 years.

The sp will now trip along at around 1p (if lucky) until they are taken over by someone who knows what their doing. That is if anyone wants them.

Traders delight.

Looks like some washing their hands of it and others trying to make a quick buck from the mm's mark down

Takeover looking more and more likely to me at bargain basement price!

Could there be a clause in the partnership which erquires a level of consumption of Biotec products?

You couldn't make it up. What will become of SEO? Will it turn into a cash shell and just become dormant. This was always going to be a loser. Just another company with investors in love with the technology and no hope of it being a real business. The list of such failed companies is very long. They have 11m in cash, but their market cap is 34m. This has some way to fall yet.


"Stanelco PLC said trading expectations for the full year will be 'adversely affected' by patent challenges"

"trials of its Greenseal product showed the application is unlikely to lead to commercial sales."

"The company put its plans to manufacture Biotec products in the US on hold"

for "further cost reductions are envisaged" read mass sackings!